WAVE Life Sciences Ltd Stock
Price
Target price
?
?
0.970%
0.1
0.970%
€18.91
08:48 / Stuttgart Stock Exchange
WKN: A1436W / Symbol: WVE / Name: WAVE Life / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
WAVE Life Sciences Ltd Stock
WAVE Life Sciences Ltd gained 0.970% compared to yesterday.
The stock is one of the favorites of our community with 24 Buy predictions and 2 Sell predictions.
As a result the target price of 18 € shows a very positive potential of 73.08% compared to the current price of 10.4 € for WAVE Life Sciences Ltd.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for WAVE Life Sciences Ltd stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of WAVE Life Sciences Ltd in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of WAVE Life Sciences Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| WAVE Life Sciences Ltd | 0.970% | -9.565% | -6.306% | 19.540% | -30.201% | 179.946% | 22.353% |
| Intellia Therapeutics Inc | -2.370% | 2.474% | 2.751% | 33.591% | 45.913% | -69.529% | -79.321% |
| Chromadex Corp | 0.500% | -6.190% | -4.831% | -44.507% | -28.364% | 164.341% | -59.171% |
| Cardio3 Biosciences S.A. | -8.360% | -3.214% | -13.141% | -53.356% | 100.741% | -64.668% | -95.664% |
Comments
WAVE Life Sciences (WVE) had its price target raised by Canaccord Genuity Group Inc. from $43.00 to $52.00. They now have a "buy" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (WVE) had its price target raised by Wedbush from $33.00 to $35.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (WVE) had its "buy" rating reaffirmed by HC Wainwright. They now have a $30.00 price target on the stock.
Show more
Ratings data for WVE provided by MarketBeat